Literature DB >> 6284115

Monoamine oxidase (MAO) activity as a determinant in human neurophysiology.

J E Pintar, X O Breakefield.   

Abstract

Several lines of evidence indicate that monoamine oxidase (MAO) activity can regulate levels of biogenic amines and neuronal activity in the nervous system. The two types of MAO activity, A and B, appear to have different domains of activity in the body. Brain tissue has both types of activity, although adrenergic neurons are thought to contain exclusively MAO-A. MAO activity can also be measured in peripheral tissues: MAO-A in cultured skin fibroblasts and placenta, and MAO-B in platelets and lymphocytes. These two types of activity are mediated by different enzyme molecules and are regulated independently by endogenous and exogenous factors including genetic determinants, hormones, and aging. In humans, inhibition of MAO-A activity leads to mood elevation in depressed patients; in contrast, low MAO-B activity in platelets has been associated with an increased susceptibility to psychopathology. In order to assess further the role of MAO activity in human mood and behavior, it will be important to measure both forms of the enzyme independently and to establish correlations between levels of activity and discrete phenotypic traits.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284115     DOI: 10.1007/bf01065740

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  51 in total

1.  Monoamine oxidase and catechol-O-methyltransferase activities in cultured human skin fibroblasts.

Authors:  J A Roth; X O Breakefield; C M Castiglione
Journal:  Life Sci       Date:  1976-12-01       Impact factor: 5.037

2.  Improved medium for clonal growth of human diploid fibroblasts at low concentrations of serum protein.

Authors:  W L McKeehan; K A McKeehan; S L Hammond; R G Ham
Journal:  In Vitro       Date:  1977-07

3.  Evidence for a specific monoamine oxidase associated with sympathetic nerves.

Authors:  C Goridis; N H Neff
Journal:  Neuropharmacology       Date:  1971-09       Impact factor: 5.250

4.  The inhibition or rat heart type A monoamine oxidase by clorgyline as a method for the estimation of enzyme active centers.

Authors:  C J Fowler; B A Callingham
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

5.  Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets.

Authors:  D S Robinson; J M Davis; A Nies; C L Ravaris; D Sylwester
Journal:  Arch Gen Psychiatry       Date:  1971-06

6.  Color blindness linkage to bipolar manic-depressive illness. New evidence.

Authors:  J Mendlewicz; P Linkowski; J J Guroff; H M Van Praag
Journal:  Arch Gen Psychiatry       Date:  1979-12

Review 7.  Environmental determination of autonomic neurotransmitter functions.

Authors:  P H Patterson
Journal:  Annu Rev Neurosci       Date:  1978       Impact factor: 12.449

8.  Dexamethasone selectively increases monoamine oxidase type A in human skin fibroblasts.

Authors:  S B Edelstein; X O Breakefield
Journal:  Biochem Biophys Res Commun       Date:  1981-02-12       Impact factor: 3.575

9.  Age related changes in the lipids of the microsomal and the mitochondrial membranes of rat liver and kidney.

Authors:  L S Grinna
Journal:  Mech Ageing Dev       Date:  1977 May-Jun       Impact factor: 5.432

10.  Familial X-linked mental retardation, verbal disability, and marker X chromosomes.

Authors:  P N Howard-Peebles; G R Stoddard; M G Mims
Journal:  Am J Hum Genet       Date:  1979-03       Impact factor: 11.025

View more
  7 in total

Review 1.  Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations.

Authors:  Yumi Yamamoto; Meindert Danhof; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2017-03-09       Impact factor: 4.009

2.  Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer.

Authors:  Meenakshi Meenu; Vipin Kumar Verma; Amlesh Seth; Ranjit Kumar Sahoo; Pooja Gupta; Dharamvir Singh Arya
Journal:  Curr Ther Res Clin Exp       Date:  2020-10-28

3.  Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.

Authors:  P Levitt; J E Pintar; X O Breakefield
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

4.  Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response.

Authors:  Pierre Mesdom; Romain Colle; Elise Lebigot; Séverine Trabado; Eric Deflesselle; Bruno Fève; Laurent Becquemont; Emmanuelle Corruble; Céline Verstuyft
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

5.  MAOI Antidepressants: Could They Be a Next-Generation ICB Therapy?

Authors:  James Brown; Bo Li; Lili Yang
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

6.  Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects.

Authors:  James Brown; Zhe Li; Xi Wang; Yu Jeong Kim; Yu-Chen Wang; Yanning Zuo; Weizhe Hong; Pin Wang; Bo Li; Lili Yang
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

7.  Noradrenaline and cortisol changes in response to low-grade cognitive stress differ in migraine and tension-type headache.

Authors:  Rune Bang Leistad; Lars Jacob Stovner; Linda R White; Kristian B Nilsen; Rolf H Westgaard; Trond Sand
Journal:  J Headache Pain       Date:  2007-06-11       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.